Correlation Between Krebs Biochemicals and Medplus Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Krebs Biochemicals and Medplus Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krebs Biochemicals and Medplus Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krebs Biochemicals and and Medplus Health Services, you can compare the effects of market volatilities on Krebs Biochemicals and Medplus Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krebs Biochemicals with a short position of Medplus Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krebs Biochemicals and Medplus Health.

Diversification Opportunities for Krebs Biochemicals and Medplus Health

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Krebs and Medplus is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Krebs Biochemicals and and Medplus Health Services in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medplus Health Services and Krebs Biochemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krebs Biochemicals and are associated (or correlated) with Medplus Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medplus Health Services has no effect on the direction of Krebs Biochemicals i.e., Krebs Biochemicals and Medplus Health go up and down completely randomly.

Pair Corralation between Krebs Biochemicals and Medplus Health

Assuming the 90 days trading horizon Krebs Biochemicals and is expected to generate 2.63 times more return on investment than Medplus Health. However, Krebs Biochemicals is 2.63 times more volatile than Medplus Health Services. It trades about 0.09 of its potential returns per unit of risk. Medplus Health Services is currently generating about 0.18 per unit of risk. If you would invest  8,860  in Krebs Biochemicals and on September 12, 2024 and sell it today you would earn a total of  1,920  from holding Krebs Biochemicals and or generate 21.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Krebs Biochemicals and  vs.  Medplus Health Services

 Performance 
       Timeline  
Krebs Biochemicals and 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Medplus Health Services 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Medplus Health Services are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Medplus Health unveiled solid returns over the last few months and may actually be approaching a breakup point.

Krebs Biochemicals and Medplus Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Krebs Biochemicals and Medplus Health

The main advantage of trading using opposite Krebs Biochemicals and Medplus Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krebs Biochemicals position performs unexpectedly, Medplus Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medplus Health will offset losses from the drop in Medplus Health's long position.
The idea behind Krebs Biochemicals and and Medplus Health Services pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Fundamental Analysis
View fundamental data based on most recent published financial statements